This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Ana De Prado Gonzalez: Innovator in Protein Kinase Inhibitors
Introduction
Ana De Prado Gonzalez is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of protein kinase inhibitors. Her work is crucial in the treatment of cell proliferative diseases, showcasing her dedication to advancing medical science.
Latest Patents
Ana holds a patent for a compound of formula (I) or a pharmaceutically acceptable salt thereof, which is useful in the treatment of cell proliferative diseases. This patent highlights her innovative approach to addressing complex health issues. She has 1 patent to her name, reflecting her impactful contributions to the industry.
Career Highlights
Ana is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role at Eli Lilly allows her to collaborate with some of the brightest minds in the industry, further enhancing her expertise and influence in the field.
Collaborations
Ana has worked alongside notable colleagues such as David Andrew Coates and Lawrence Mark Gelbert. These collaborations have enriched her research and development efforts, fostering an environment of innovation and creativity.
Conclusion
Ana De Prado Gonzalez is a remarkable inventor whose work in protein kinase inhibitors is paving the way for new treatments in medicine. Her contributions are vital to the ongoing fight against cell proliferative diseases, and her career continues to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile